FDA clears innovative device for pancreatic cancer treatment
Mornings With Maria · FBN · Feb 20, 2026 · 54sSign Up NowAlready a subscriber?
Dr. Marty Makary discusses the FDA's approval of NovoCure's device for treating locally advanced pancreatic cancer. He highlights the profound impact of this disease on patients and emphasizes the FDA's urgent focus on accelerating the approval process for therapies targeting metastatic pancreatic cancer, stating that a ten-year development timeline is unacceptable for such critical needs. Maria Bartiromo expresses support for these efforts.